Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
The Journal of Headache and Pain
Published in: The Journal of Headache and Pain 1/2007

Open Access 01-02-2007 | Spotlight

Patent foramen ovale and migraine: no reason to intervene

Authors: Hans-Christoph Diener, on behalf of the Council of the European Headache Federation

Published in: The Journal of Headache and Pain | Issue 1/2007

Login to get access

Excerpt

Cardiac embolism is the most frequent cause of ischaemic stroke in hospital-based and population-based registers. Patent foramen ovale (PFO) with and without atrial septal aneurysm (ASA) has been recognised as a potential risk factor for ischaemic stroke. Besides paradoxical embolism from small thrombi that arise in the venous system and cardiac thrombus formation secondary to PFO/ASA-related cardiac arrhythmia, another likely ischaemic stroke cause is thrombus formation in the PFO. …
Literature
1.
Del Sette M, Angeli S, Leandri M et al (1998) Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 8:327–330CrossRefPubMed
2.
Anzola GP, Magoni M, Guindani M et al (1999) Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 52:1622–1625CrossRefPubMed
3.
Schwerzmann M, Nedeltchev K, Lagger F et al (2005) Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 65:1415–1418CrossRefPubMed
4.
Carod-Artal FJ, da Silveira Ribeiro L, Braga H et al (2006) Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial Doppler study. Cephalalgia 26:934–939CrossRefPubMed
5.
Wilmshurst PT, Pearson MJ, Nightingale S et al (2004) Inheritance of persistent foramen ovale and atrial septal defects and the relationship to familial migraine with aura. Heart 90:1245–1247CrossRef
6.
Lampl C, Bonelli S, Ransmayr G (2004) Efficacy of topiramate in migraine aura prophylaxis: preliminary results of 12 patients. Headache 44:174–177CrossRefPubMed
7.
Lampl C, Katsarava Z, Diener HC, Limmroth V (2005) Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 76:1730–1732PubMedCentralCrossRefPubMed
8.
Schwerzmann M, Wiher S, Nedeltchev K et al (2004) Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 62:1399–1401CrossRefPubMed
9.
Post M, Thijs V, Herroelen L, Budts W (2004) Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 62:1439–1440CrossRefPubMed
10.
Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL (2000) Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 356:1648–1651CrossRefPubMed
11.
Mortelmans K, Post M, Thijs V et al (2005) The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J 26:1533–1537CrossRefPubMed
12.
Reisman M, Christofferson RD, Jesurum J et al (2005) Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 45:493–495CrossRefPubMed
13.
Azarbal B, Tobis J, Suh W et al (2005) Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol 45:489–492CrossRefPubMed
14.
Anzola GP, Frisoni GB, Morandi E et al (2006) Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke 37:430–434CrossRefPubMed
15.
Buring JE, Peto R, Hennekens CH (1990) Low-dose aspirin for migraine prophylaxis. JAMA 264:1711–1713CrossRefPubMed
16.
Diener HC, Hartung E, Chrubasik J et al (2001) A comparative study of acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomised, controlled, double-blind, parallel group phase III study. Cephalalgia 21:140–144CrossRefPubMed
17.
Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL (2005) Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart 91:1173–1175PubMedCentralCrossRefPubMed
18.
Sharifi M, Burks J (2004) Efficacy of clopidogrel in the treatment of post-ASD closure migraines. Catheter Cardiovasc Interv 63:255CrossRefPubMed
Metadata
Title
Patent foramen ovale and migraine: no reason to intervene
Authors
Hans-Christoph Diener
on behalf of the Council of the European Headache Federation
Publication date
01-02-2007
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue 1/2007
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1007/s10194-007-0353-8

Other articles of this Issue 1/2007

The Journal of Headache and Pain 1/2007 Go to the issue

RAPID COMMUNICATION

Aspirin and tension-type headache

Brief Report

Atypical primary headache responding to finger pressure: possible involvement of the vagus nerve?

Original

Present and previous psychopathology of juvenile onset migraine: a pilot investigation by Child Behavior Checklist

Original

The rare, unilateral headaches. Vågå study of headache epidemiology

Original

Health-related quality of life among Canadians with migraine

Editorial

Advancing towards a crescendo in 2007